1. An outline of procedures for preliminary toxicologic and pharmacologic evaluation of experimental cancer chemotherapeutic agents. Cancer Chemother. Rep. 37, 1–34 (1964).
2. Andrews, N.C., Wilson, W.L.: Phase II study of methotrexate (NSC-740) in solid tumors. Cancer Chemother. Rep. 51, 471–474 (1967).
3. Anglesio, E., Hirschberg, E., Gellhorn, A.: Effects of carcinostatic and other biologically active compounds in the normal rat: evaluation as a system for cancer chemotherapy screening. Cancer Res. 18, 113–116 (1958).
4. Bergenstal, D.M., Hertz, R., Lipsett, M., Moy, R. H.: Chemotherapy of adrenocortical cancer with o,p′-DDD. Ann. int. Med. 53, 672–682 (1960).
5. Bodey, G., Freireich, E., Monto, R.W., Hewlett, J.S.: Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. Cancer Chemother. Rep. 53, 59–66 (1969).